EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Association of Amiodarone Use Prior to Orthotopic Heart Transplant with Post-Transplant Graft Dysfunction and All-Cause Mortality: A Systematic Review and Meta-Analysis

Elizabeth Ko, Mohammad Ahmed, Matthew Nudy, Rahul Bussa, Jatin Bussa, Mario Gonzalez, Gerald Naccarelli, Behzad Soleimani, Ankit Maheshwari

Journal of Cardiac Failure · 2025-01 · 31 (1) · 149-153

DOI: 10.1016/j.cardfail.2024.06.014 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cardiac Failure, 2025-01. Verfasst von Elizabeth Ko und 8 weiteren Autor:innen. Beteiligte Einrichtung: Penn State Hershey Medical Center, Department of Internal Medicine, Hershey, Pennsylvania. Electronic address: elizabethko@pennstatehealth.psu.edu. Hauptthemen laut MEDLINE: Amiodarone, Heart Transplantation, Anti-Arrhythmia Agents, Primary Graft Dysfunction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: There is conflicting data on the association between pre-orthotopic heart transplant (OHT) amiodarone use and post-OHT graft dysfunction (GD) leading to heterogeneity in clinical practice. METHODS: We performed a meta-analysis to evaluate whether pre-OHT amiodarone use was associated with meaningful increases in the incidence of GD, 30-day mortality, and 1-year mortality. Studies were identified by searching PubMed and the Cochrane Register of Clinical Trials. The Mantel-Haenszel method was used to calculate odds ratios (OR) and 95% confidence intervals (CI95) for each endpoint. RESULTS: 17 retrospective studies were identified that included 48,782 patients. 14 studies (n = 48,018) reported GD as an outcome. Pre-OHT amiodarone use was associated with increased odds of GD (OR 1.3, CI95 1.2-1.5, p < 0.001). 10 studies (n = 45,875) reported 30-day mortality based on amiodarone use. Pre-OHT amiodarone use was associated with increased odds of 30-day mortality (OR 1.4, CI95 1.2-1.5, p < 0.001). 5 studies (n = 41,404) reported 1-year mortality based on amiodarone use. Pre-OHT amiodarone use was associated with increased odds of 1-year mortality (OR 1.2, CI95 1.1-1.4, p < 0.001). The increase in absolute risk of GD, 30-day mortality, and 1-year mortality for patients with pre-OHT amiodarone use was 1.3%, 1.2%, and 1.4%, respectively. CONCLUSION: Pre-OHT amiodarone exposure was associated with increased odds of GD, 30-day mortality, and 1-year mortality. The increase in absolute risk for each endpoint was modest, and it is unclear to what extent, if any, pre-OHT amiodarone use should influence assessment of OHT candidacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmiodaroneHeart TransplantationAnti-Arrhythmia AgentsPrimary Graft DysfunctionHeart FailureHumansCause of DeathMortality

Stichwörter der Autor:innen

Heart transplantationamiodaronemortalityprimary graft dysfunction

Substanzen

AmiodaroneAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Penn State Hershey Medical Center, Department of Internal Medicine, Hershey, Pennsylvania. Electronic address: elizabethko@pennstatehealth.psu.edu.
  • Penn State Hershey Medical Center, Heart and Vascular Institute, Division of Cardiology, Hershey, Pennsylvania.
  • Penn State Hershey Medical Center, Heart and Vascular Institute, Division of Cardiology, Hershey, Pennsylvania; Penn State Hershey Medical Center, Department of Public Health Sciences, Hershey, Pennsylvania.
  • Penn State Hershey Medical Center, Department of Internal Medicine, Hershey, Pennsylvania.
  • University of Massachusetts Amherst, Department of Biochemistry and Molecular Biology, Amherst, Massachusetts.

Zitieren

APA

Ko, E., Ahmed, M., Nudy, M., Bussa, R., Bussa, J., Gonzalez, M., Naccarelli, G., Soleimani, B., & Maheshwari, A. (2025). Association of Amiodarone Use Prior to Orthotopic Heart Transplant with Post-Transplant Graft Dysfunction and All-Cause Mortality: A Systematic Review and Meta-Analysis. Journal of Cardiac Failure, 31(1), 149-153. https://doi.org/10.1016/j.cardfail.2024.06.014

Vancouver

Ko E, Ahmed M, Nudy M, Bussa R, Bussa J, Gonzalez M, et al. Association of Amiodarone Use Prior to Orthotopic Heart Transplant with Post-Transplant Graft Dysfunction and All-Cause Mortality: A Systematic Review and Meta-Analysis. Journal of Cardiac Failure. 2025;31(1):149-153. doi:10.1016/j.cardfail.2024.06.014

BibTeX
@article{Ko2025,
  author = {Ko, Elizabeth and Ahmed, Mohammad and Nudy, Matthew and Bussa, Rahul and Bussa, Jatin and Gonzalez, Mario and Naccarelli, Gerald and Soleimani, Behzad and Maheshwari, Ankit},
  title = {Association of Amiodarone Use Prior to Orthotopic Heart Transplant with Post-Transplant Graft Dysfunction and All-Cause Mortality: A Systematic Review and Meta-Analysis},
  journal = {Journal of Cardiac Failure},
  year = {2025},
  volume = {31},
  number = {1},
  pages = {149--153},
  doi = {10.1016/j.cardfail.2024.06.014}
}
Kostenlos starten →